Literature DB >> 21093113

Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.

Ping Lan1, Wan-Na Chen, Wei-Min Chen.   

Abstract

3D-QSAR and docking studies were performed on sixty imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors. The CoMFA and CoMSIA models using forthy-eight molecules in the training set, gave r(cv)(2) values of 0.774 and 0.800, r(2) values of 0.975 and 0.977, respectively. The external validation indicated that both CoMFA and CoMSIA models possessed high predictive powers with r(pred)(2) values of 0.933 and 0.959, r(m)(2) values of 0.883 and 0.915, respectively. 3D contour maps generated from the two models along with docking binding structures have identified several key structural requirements responsible for the activity. A set of thirty new analogues were proposed by utilizing the results revealed in the present study, and were predicted with significantly improved potencies in the developed models.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093113     DOI: 10.1016/j.ejmech.2010.10.017

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  11 in total

1.  Molecular modeling studies on phosphonic acid-containing thiazole derivatives: design for fructose-1,6-bisphosphatase inhibitors.

Authors:  Ping Lan; Zhi-Wei Wu; Wan-Na Chen; Ping-Hua Sun; Wei-Min Chen
Journal:  J Mol Model       Date:  2011-06-05       Impact factor: 1.810

2.  In vitro studies on the interaction between human serum albumin and fosfomycin disodium salt, an antibiotic drug by multi-spectroscopic and molecular docking methods.

Authors:  Manjunath D Meti; Kirthi S Byadagi; Sharanappa T Nandibewoor; Shrinivas D Joshi; Uttam A More; Shivamurti A Chimatadar
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

3.  In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies.

Authors:  M C Sharma; S Jain; R Sharma
Journal:  In Silico Pharmacol       Date:  2017-10-23

4.  Benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one derivatives as Aurora A kinase inhibitors: LQTA-QSAR analysis and detailed systematic validation of the developed model.

Authors:  Ashish M Kanhed; Radha Charan Dash; Nishant Parmar; Tarun Kumar Das; Rajani Giridhar; Mange Ram Yadav
Journal:  Mol Divers       Date:  2015-07-17       Impact factor: 2.943

5.  Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors.

Authors:  Yuanxin Tian; Jian Xu; Zhonghuang Li; Zhengguang Zhu; Jiajie Zhang; Shuguang Wu
Journal:  Int J Mol Sci       Date:  2011-08-10       Impact factor: 5.923

6.  Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors.

Authors:  Yong Ai; Shao-Teng Wang; Ping-Hua Sun; Fa-Jun Song
Journal:  Int J Mol Sci       Date:  2011-03-01       Impact factor: 5.923

7.  The three dimensional Quantitative Structure Activity Relationships (3D-QSAR) and docking studies of curcumin derivatives as androgen receptor antagonists.

Authors:  Guanhong Xu; Yanyan Chu; Nan Jiang; Jing Yang; Fei Li
Journal:  Int J Mol Sci       Date:  2012-05-18       Impact factor: 6.208

8.  Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method.

Authors:  Mingwei Wu; Yan Li; Xinmei Fu; Jinghui Wang; Shuwei Zhang; Ling Yang
Journal:  Int J Mol Sci       Date:  2014-09-01       Impact factor: 5.923

9.  CoMFA, CoMSIA, HQSAR and Molecular Docking Analysis of Ionone-based Chalcone Derivatives as Antiprostate Cancer Activity.

Authors:  R Sharma; N Dhingra; S Patil
Journal:  Indian J Pharm Sci       Date:  2016 Jan-Feb       Impact factor: 0.975

Review 10.  Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.

Authors:  Malwina Krause; Henryk Foks; Katarzyna Gobis
Journal:  Molecules       Date:  2017-03-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.